Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.10.23 | AstraZeneca: IMFINZI (durvalumab) plus LYNPARZA (olaparib) reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer | 776 | Business Wire | IMFINZI reduced the risk of disease progression or death by 29% vs. chemotherapy First Phase III trial to demonstrate clinical benefit of immunotherapy plus PARP inhibition in advanced or recurrent... ► Artikel lesen | |
21.10.23 | AnHeart Therapeutics' Investigational Medicine Taletrectinib Shrank Tumors in More Than 90 Percent of People With ROS1-Positive Non-Small Cell Lung Cancer Who Were ROS1 TKI Naïve in Global Pivotal TRUST-II Trial | 555 | Business Wire | Taletrectinib also shrank tumors in 57 percent of people with ROS1-positive NSCLC who had previously been treated with a ROS1 TKI in the trial Taletrectinib continues to be generally well tolerated... ► Artikel lesen | |
21.10.23 | Aviapartner Extends Footprint Through Joint Venture With South Africa | 513 | Business Wire | Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa. With this partnership, the Belgium headquartered... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 3.988 |
TESLA | 3.356 |
DEUTSCHE BANK | 2.508 |
NEL | 1.861 |
BYD | 1.738 |
NVIDIA | 1.413 |
BAYER | 1.269 |
TUI | 1.256 |
SUPER MICRO COMPUTER | 1.064 |
RHEINMETALL | 982 |
AIXTRON SE | 894 |
COMMERZBANK | 810 |
PHILIPS | 779 |
BASF | 754 |
RWE | 733 |
MERCEDES-BENZ | 707 |
JINKOSOLAR | 696 |
AMAZON | 655 |
META PLATFORMS | 654 |
PLUG POWER | 646 |
THYSSENKRUPP | 629 |
DELIVERY HERO | 618 |
HEIDELBERGER DRUCK | 604 |
SIEMENS ENERGY | 582 |
PAYPAL | 547 |